128 related articles for article (PubMed ID: 30328797)
1. Interleukin-23: A New Atherosclerosis Target.
Liu W; Chang C; Hu H; Yang H
J Interferon Cytokine Res; 2018 Oct; 38(10):440-444. PubMed ID: 30328797
[TBL] [Abstract][Full Text] [Related]
2. IL-23 and dendritic cells: What are the roles of their mutual attachment in immune response and immunotherapy?
Li Y; Yu X; Ma Y; Hua S
Cytokine; 2019 Aug; 120():78-84. PubMed ID: 31029042
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-23-induced interleukin-23 receptor subunit expression is mediated by the Janus kinase/signal transducer and activation of transcription pathway in human CD4 T cells.
Che Mat NF; Zhang X; Guzzo C; Gee K
J Interferon Cytokine Res; 2011 Apr; 31(4):363-71. PubMed ID: 21138378
[TBL] [Abstract][Full Text] [Related]
4. Dendritic Cells Exposed to Triiodothyronine Deliver Pro-Inflammatory Signals and Amplify IL-17-Driven Immune Responses.
Alamino VA; Montesinos MDM; Soler MF; Giusiano L; Gigena N; Fozzatti L; Maller SM; Méndez-Huergo SP; Rabinovich GA; Pellizas CG
Cell Physiol Biochem; 2019; 52(2):354-367. PubMed ID: 30816679
[TBL] [Abstract][Full Text] [Related]
5. Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17
Su Y; Wang Q; Yang B; Wu L; Cheng G; Kuang H
Clin Exp Immunol; 2017 Oct; 190(1):40-53. PubMed ID: 28617942
[TBL] [Abstract][Full Text] [Related]
6. IL-35: a potential target for the treatment of atherosclerosis.
Huang Y; Lin YZ; Shi Y; Ji QW
Pharmazie; 2013 Oct; 68(10):793-5. PubMed ID: 24273881
[TBL] [Abstract][Full Text] [Related]
7. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
Yang J; Xu L
Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
[TBL] [Abstract][Full Text] [Related]
8. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
9. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.
Parham C; Chirica M; Timans J; Vaisberg E; Travis M; Cheung J; Pflanz S; Zhang R; Singh KP; Vega F; To W; Wagner J; O'Farrell AM; McClanahan T; Zurawski S; Hannum C; Gorman D; Rennick DM; Kastelein RA; de Waal Malefyt R; Moore KW
J Immunol; 2002 Jun; 168(11):5699-708. PubMed ID: 12023369
[TBL] [Abstract][Full Text] [Related]
10. Microglia express a functional receptor for interleukin-23.
Sonobe Y; Liang J; Jin S; Zhang G; Takeuchi H; Mizuno T; Suzumura A
Biochem Biophys Res Commun; 2008 May; 370(1):129-33. PubMed ID: 18358830
[TBL] [Abstract][Full Text] [Related]
11. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
[TBL] [Abstract][Full Text] [Related]
13. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
[TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
15. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.
Watford WT; Hissong BD; Bream JH; Kanno Y; Muul L; O'Shea JJ
Immunol Rev; 2004 Dec; 202():139-56. PubMed ID: 15546391
[TBL] [Abstract][Full Text] [Related]
16. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
Okada S; Han S; Patel ES; Yang LJ; Chang LJ
Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
[TBL] [Abstract][Full Text] [Related]
17. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
[TBL] [Abstract][Full Text] [Related]
19. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.
de Paus RA; van de Wetering D; van Dissel JT; van de Vosse E
Mol Immunol; 2008 Sep; 45(15):3889-95. PubMed ID: 18675459
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
